First Manhattan’s Celgene Corporation Contingent Value Rights CELGZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-5,000
| Closed | -$2K | – | 1428 |
|
|
2019
Q3 | $2K | Hold |
5,000
| – | – | ﹤0.01% | 1277 |
|
|
2019
Q2 | $3K | Hold |
5,000
| – | – | ﹤0.01% | 1300 |
|
|
2019
Q1 | $5K | Hold |
5,000
| – | – | ﹤0.01% | 1278 |
|
|
2018
Q4 | $2K | Hold |
5,000
| – | – | ﹤0.01% | 1314 |
|
|
2018
Q3 | $8K | Hold |
5,000
| – | – | ﹤0.01% | 1257 |
|
|
2018
Q2 | $2K | Hold |
5,000
| – | – | ﹤0.01% | 1311 |
|
|
2018
Q1 | $1K | Hold |
5,000
| – | – | ﹤0.01% | 1366 |
|
|
2017
Q4 | $4K | Sell |
5,000
-3,000
| -38% | -$3.45K | ﹤0.01% | 1351 |
|
|
2017
Q3 | $12K | Sell |
8,000
-2,000
| -20% | -$2.44K | ﹤0.01% | 1202 |
|
|
2017
Q2 | $12K | Sell |
10,000
-3,000
| -23% | -$3.44K | ﹤0.01% | 1155 |
|
|
2017
Q1 | $14K | Hold |
13,000
| – | – | ﹤0.01% | 1152 |
|
|
2016
Q4 | $13K | Hold |
13,000
| – | – | ﹤0.01% | 1138 |
|
|
2016
Q3 | $13K | Hold |
13,000
| – | – | ﹤0.01% | 1152 |
|
|
2016
Q2 | $18K | Hold |
13,000
| – | – | ﹤0.01% | 1130 |
|
|
2016
Q1 | $17K | Hold |
13,000
| – | – | ﹤0.01% | 1089 |
|
|
2015
Q4 | $15K | Sell |
13,000
-39,000
| -75% | -$51.9K | ﹤0.01% | 1126 |
|
|
2015
Q3 | $83K | Hold |
52,000
| – | – | ﹤0.01% | 843 |
|
|
2015
Q2 | $108K | Hold |
52,000
| – | – | ﹤0.01% | 808 |
|
|
2015
Q1 | $154K | Hold |
52,000
| – | – | ﹤0.01% | 746 |
|
|
2014
Q4 | $163K | Hold |
52,000
| – | – | ﹤0.01% | 735 |
|
|
2014
Q3 | $176K | Hold |
52,000
| – | – | ﹤0.01% | 709 |
|
|
2014
Q2 | $135K | Hold |
52,000
| – | – | ﹤0.01% | 755 |
|
|
2014
Q1 | $146K | Buy |
52,000
+23,000
| +79% | +$69.5K | ﹤0.01% | 728 |
|
|
2013
Q4 | $79K | Buy |
29,000
+28,000
| +2,800% | +$78.6K | ﹤0.01% | 851 |
|
|
2013
Q3 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 1212 |
|
|
2013
Q2 | $7K | Buy |
+1,000
| New | +$7.25K | ﹤0.01% | 1209 |
|
First Manhattan's CELGZ Position: Q4 2019 in Review
First Manhattan sold out of Celgene Corporation Contingent Value Rights (CELGZ) in Q4 2019, closing a stake of 5,000 shares — an estimated $2K sold.
First Manhattan first reported a position in CELGZ in Q2 2013 and held it in 26 quarters. The position peaked at $176K in Q3 2014. 0 funds tracked by Wall St. Rank hold CELGZ as of Q4 2019.
- First Manhattan reported no remaining Celgene Corporation Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
- First Manhattan sold 5,000 Celgene Corporation Contingent Value Rights shares in Q4 2019, an estimated $2K.
- First Manhattan first reported a position in Celgene Corporation Contingent Value Rights in Q2 2013 and held it in 26 quarters.
- First Manhattan's Celgene Corporation Contingent Value Rights position peaked at $176K in Q3 2014.
- 0 funds tracked by Wall St. Rank held Celgene Corporation Contingent Value Rights as of Q4 2019.
Based on First Manhattan's 13F filing for Q4 2019, filed 13 Feb 2020.